Systemic corticosteroid therapy significantly decreased length of hospital stay and fever duration in children with community-acquired pneumonia
This systematic review and meta-analysis assessed the impact of systemic corticosteroid therapy compared with controls in children with community-acquired pneumonia. The analysis included a sample size of N = 75.353 patients across studies where the setting was not reported.
Key findings indicated a significantly decreased length of hospital stay with a Cohen's d value of -0.59 and a 95% confidence interval of -0.96 to -0.23, P = 0.001. Additionally, the duration of fever was significantly decreased with a Cohen's d value of -0.54 and a 95% confidence interval of -0.83 to -0.26, P < 0.001. Secondary outcomes included radiologic recovery time and clinical recovery time.
The authors noted significant heterogeneity regarding the regimen, dosage, and duration of corticosteroid therapy. Results were not significant in observational studies. Adverse events were described as infrequent and manageable, while serious adverse events, discontinuations, and tolerability were not reported. The study acknowledges limitations related to heterogeneity and the lack of significance in observational data.